Literature DB >> 12209131

Cyclic nucleotide research -- still expanding after half a century.

Joseph A Beavo1, Laurence L Brunton.   

Abstract

Since the discovery in 1957 that cyclic AMP acts as a second messenger for the hormone adrenaline, interest in this molecule and its companion, cyclic GMP, has grown. Over a period of nearly 50 years, research into second messengers has provided a framework for understanding transmembrane signal transduction, receptor-effector coupling, protein-kinase cascades and downregulation of drug responsiveness. The breadth and impact of this work is reflected by five different Nobel prizes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209131     DOI: 10.1038/nrm911

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  290 in total

1.  An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.

Authors:  Christopher K Means; Birgitte Lygren; Lorene K Langeberg; Ankur Jain; Rose E Dixon; Amanda L Vega; Matthew G Gold; Susanna Petrosyan; Susan S Taylor; Anne N Murphy; Taekjip Ha; Luis F Santana; Kjetil Tasken; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

Review 2.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Authors:  Thérèse Keravis; Claire Lugnier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  The A-kinase-anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Ser(16).

Authors:  Helen V Edwards; John D Scott; George S Baillie
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

Review 4.  A-kinase anchoring proteins: getting to the heart of the matter.

Authors:  John D Scott; Luis F Santana
Journal:  Circulation       Date:  2010-03-16       Impact factor: 29.690

5.  Computational determination of binding structures and free energies of phosphodiesterase-2 with benzo[1,4]diazepin-2-one derivatives.

Authors:  Bo Yang; Adel Hamza; Guangju Chen; Yan Wang; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-11-15       Impact factor: 2.991

6.  Distinct roles of adenylyl cyclase VII in regulating the immune responses in mice.

Authors:  Biyan Duan; Richard Davis; Eva L Sadat; Julie Collins; Paul C Sternweis; Dorothy Yuan; Lily I Jiang
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

7.  Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.

Authors:  Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal:  J Mol Cell Cardiol       Date:  2015-09-23       Impact factor: 5.000

8.  The mRNA-destabilizing protein Tristetraprolin targets "meiosis arrester" Nppc mRNA in mammalian preovulatory follicles.

Authors:  Guangyin Xi; Lei An; Wenjing Wang; Jing Hao; Qianying Yang; Lizhu Ma; Jinlun Lu; Yue Wang; Wenjuan Wang; Wei Zhao; Juan Liu; Mingyao Yang; Xiaodong Wang; Zhenni Zhang; Chao Zhang; Meiqiang Chu; Yuan Yue; Fusheng Yao; Meijia Zhang; Jianhui Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

9.  A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells.

Authors:  Wiebke Wolfsgruber; Susanne Feil; Sabine Brummer; Oliver Kuppinger; Franz Hofmann; Robert Feil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 10.  Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights.

Authors:  Clemens C Heikaus; Jayvardhan Pandit; Rachel E Klevit
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.